FABP7 and central nervous system cancer: One of the criteria used to define glioma stem cells is the expression of stem cell markers, including CD133 (prominin-1), sox2, Olig2, nestin, brain lipid binding protein (BLBP), and CD44, which derive from studies on both CNS and non-CNS progenitor cell populations [70-71].